{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:45:43Z","timestamp":1789677943839,"version":"4.0.1"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007427","name":"MPN Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Chronic inflammation is integral to myeloproliferative neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptoms in MPN. We performed a randomized, parallel-arm study to determine the feasibility of an education-focused Mediterranean diet intervention among patients with MPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Design:<\/jats:title>\n                    <jats:p>We randomly assigned patients with MPN to either a Mediterranean diet or standard U.S. Dietary Guidelines for Americans (USDA). Groups received equal but separate education with registered dietician counseling and written dietary resources. Patients were prospectively followed for feasibility, adherence, and symptom burden assessments. Biological samples were collected at four timepoints during the 15-week study to explore changes in inflammatory biomarkers and gut microbiome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The Mediterranean diet was as easy to follow for patients with MPN as the standard USDA diet. Approximately 80% of the patients in the Mediterranean diet group achieved a Mediterranean Diet Adherence Score of \u22658 throughout the entire active intervention period, whereas less than 50% of the USDA group achieved a score of \u22658 at any timepoint. Improvement in symptom burden was observed in both diet groups. No significant changes were observed in inflammatory cytokines. The diversity and composition of the gut microbiome remained stable throughout the duration of the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>With dietician counseling and written education, patients with MPN can adhere to a Mediterranean eating pattern. Diet interventions may be further developed as a component of MPN care, and potentially incorporated into the management of other hematologic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Diet is a central tenant of management of chronic conditions characterized by subclinical inflammation, such as cardiovascular disease, but has not entered the treatment algorithm for clonal hematologic disorders. Here, we establish that a Mediterranean diet intervention is feasible in the MPN patient population and can improve symptom burden. These findings warrant large dietary interventions in patients with hematologic disorders to test the impact of diet on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0380","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T09:00:00Z","timestamp":1708678800000},"page":"660-670","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0966-9339","authenticated-orcid":true,"given":"Laura F.","family":"Mendez Luque","sequence":"first","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."},{"name":"2Teaching and Research Department, Institute of Public Health Services of the State of Baja California, Baja California, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4710-7182","authenticated-orcid":true,"given":"Julio","family":"Avelar-Barragan","sequence":"additional","affiliation":[{"name":"3Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3166-7299","authenticated-orcid":true,"given":"Hellen","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2226-1306","authenticated-orcid":true,"given":"Jenny","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-9095","authenticated-orcid":true,"given":"Eli M.","family":"Soyfer","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-1959","authenticated-orcid":true,"given":"Jiarui","family":"Liu","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5778-5046","authenticated-orcid":true,"given":"Jane H.","family":"Chen","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-3362","authenticated-orcid":true,"given":"Nitya","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9528-3632","authenticated-orcid":true,"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-9516","authenticated-orcid":true,"given":"Heidi E.","family":"Kosiorek","sequence":"additional","affiliation":[{"name":"4Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-1085","authenticated-orcid":true,"given":"Amylou","family":"Dueck","sequence":"additional","affiliation":[{"name":"4Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9244-700X","authenticated-orcid":true,"given":"Alexander","family":"Himstead","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-2687","authenticated-orcid":true,"given":"Elena","family":"Heide","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-633X","authenticated-orcid":true,"given":"Melinda","family":"Lem","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-3004","authenticated-orcid":true,"given":"Kenza","family":"El Alaoui","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-0421","authenticated-orcid":true,"given":"Eduard","family":"Mas","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-5679","authenticated-orcid":true,"given":"Robyn M.","family":"Scherber","sequence":"additional","affiliation":[{"name":"5Mays Cancer Center, UT Health San Antonio, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-7972","authenticated-orcid":true,"given":"Ruben A.","family":"Mesa","sequence":"additional","affiliation":[{"name":"6Atrium Health, Levine Cancer Institute, Charlotte, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-6014","authenticated-orcid":true,"given":"Katrine L.","family":"Whiteson","sequence":"additional","affiliation":[{"name":"3Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-8398","authenticated-orcid":true,"given":"Andrew","family":"Odegaard","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-6079","authenticated-orcid":true,"given":"Angela G.","family":"Fleischman","sequence":"additional","affiliation":[{"name":"1University of California, Irvine School of Medicine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"2024030514014369000_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"2024030514014369000_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"2024030514014369000_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"2024030514014369000_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"2024030514014369000_bib5","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"2024030514014369000_bib6","doi-asserted-by":"crossref","first-page":"284706","DOI":"10.1155\/2015\/284706","article-title":"Impact of inflammation on myeloproliferative neoplasm symptom development","volume":"2015","author":"Geyer","year":"2015","journal-title":"Mediat Inflamm"},{"key":"2024030514014369000_bib7","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNFalpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"key":"2024030514014369000_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/cancers10040104","article-title":"The critical role of inflammation in the pathogenesis and progression of myeloid malignancies","volume":"10","author":"Craver","year":"2018","journal-title":"Cancers"},{"key":"2024030514014369000_bib9","doi-asserted-by":"crossref","first-page":"606819","DOI":"10.1155\/2015\/606819","article-title":"Inflammation as a driver of clonal evolution in myeloproliferative neoplasm","volume":"2015","author":"Fleischman","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2024030514014369000_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"2024030514014369000_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.6625","article-title":"Association of cytokine levels and reductions in spleen size in COMFORT-II, a phase III study comparing ruxolitinib to best available therapy (BAT)","volume":"30","author":"Harrison","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024030514014369000_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/bjh.12375","article-title":"Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy","volume":"162","author":"Harrison","year":"2013","journal-title":"Br J Haematol"},{"key":"2024030514014369000_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2012.44.4489","article-title":"Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Mesa","year":"2013","journal-title":"J Clin Oncol"},{"key":"2024030514014369000_bib14","first-page":"1062","article-title":"Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2\/STAT3","volume":"135","author":"Molle","year":"2020","journal-title":"Blood"},{"key":"2024030514014369000_bib15","first-page":"508","article-title":"Aggressive skin cancers occurring in patients treated with the janus kinase inhibitor ruxolitinib","volume":"16","author":"Blechman","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"2024030514014369000_bib16","article-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Myeloproliferative Neoplasms Volume Version 2.20222022","author":"NCCN"},{"key":"2024030514014369000_bib17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S0007114511005460","article-title":"Dietary factors and low-grade inflammation in relation to overweight and obesity","volume":"106","author":"Calder","year":"2011","journal-title":"Br J Nutr"},{"key":"2024030514014369000_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"2024030514014369000_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0029665110001539","article-title":"Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study","volume":"69","author":"Estruch","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"2024030514014369000_bib20","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.1182\/blood-2022-160241","article-title":"Microbial changes in response to a plant-based diet and\/or supplements in SMM patients: a national multi-arm randomized prospective telehealth study via healthtree: the nutrition prevention (NUTRIVENTION-2) study","volume":"140","author":"Castro","year":"2022","journal-title":"Blood"},{"key":"2024030514014369000_bib21","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1158\/1078-0432.CCR-22-0723","article-title":"Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets","volume":"28","author":"Shah","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2024030514014369000_bib22","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2021-151049","article-title":"A pilot plant-based dietary intervention in overweight and obese patients with monoclonal gammopathy of undetermined significance and smoldering multiple myeloma- the nutrition prevention (NUTRIVENTION) study","volume":"138","author":"Shah","year":"2021","journal-title":"Blood"},{"key":"2024030514014369000_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.appet.2016.12.029","article-title":"Nutrition knowledge and Mediterranean diet adherence in the southeast United States: validation of a field-based survey instrument","volume":"111","author":"Bottcher","year":"2017","journal-title":"Appetite"},{"key":"2024030514014369000_bib24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","article-title":"Update of the healthy eating index: HEI-2015","volume":"118","author":"Krebs-Smith","year":"2018","journal-title":"J Acad Nutr Diet"},{"key":"2024030514014369000_bib25","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","article-title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs","volume":"30","author":"Emanuel","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024030514014369000_bib26","doi-asserted-by":"crossref","DOI":"10.17504\/protocols.io.be6rjhd6","article-title":"Low Volume Methodology for Nextera DNA Flex Library Prep Kit (96 Samples)","author":"Adams","year":"2020"},{"key":"2024030514014369000_bib27","doi-asserted-by":"crossref","first-page":"e65088","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3","volume":"10","author":"Beghini","year":"2021","journal-title":"Elife"},{"key":"2024030514014369000_bib28","article-title":"Vegan R package: community ecology package 2019","author":"Oksanen"},{"key":"2024030514014369000_bib29","article-title":"nlme: linear and nonlinear mixed effects models, v3.1\u2013148 2020","author":"Pinheiro"},{"key":"2024030514014369000_bib30","doi-asserted-by":"crossref","first-page":"e0230823","DOI":"10.1128\/mbio.02308-23","article-title":"Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention","volume":"14","author":"Avelar-Barragan","year":"2023","journal-title":"mBio"},{"key":"2024030514014369000_bib31","doi-asserted-by":"crossref","first-page":"e43134","DOI":"10.1371\/journal.pone.0043134","article-title":"A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial","volume":"7","author":"Martinez-Gonzalez","year":"2012","journal-title":"PLoS One"},{"key":"2024030514014369000_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/advances\/nmy013","article-title":"Microbiome-mediated effects of the mediterranean diet on inflammation","volume":"9","author":"Bailey","year":"2018","journal-title":"Adv Nutr"},{"key":"2024030514014369000_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00394-015-1063-2","article-title":"Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota","volume":"56","author":"Mart\u00edn-Pel\u00e1ez","year":"2017","journal-title":"Eur J Nutr"},{"key":"2024030514014369000_bib34","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fphar.2019.01366","article-title":"Effect of mediterranean diet enriched in high quality extra virgin olive oil on oxidative stress, inflammation and gut microbiota in obese and normal weight adult subjects","volume":"10","author":"Luisi","year":"2019","journal-title":"Front Pharmacol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0380\/3418800\/crc-23-0380.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/660\/3421890\/crc-23-0380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/3\/660\/3421890\/crc-23-0380.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T09:03:20Z","timestamp":1709629400000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/3\/660\/735065\/The-NUTRIENT-Trial-NUTRitional-Intervention-among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,5]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0380","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25342769.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342781","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342781.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342763","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342751","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342775.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342772.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342745","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342778.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342787","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342784.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342775","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342769","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342757","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342763.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342739","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342760.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342766.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342745.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342739.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342751.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342784","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342772","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342760","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342778","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342766","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342754.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342754","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342742","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342736.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342748","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342736","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342757.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342787.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342748.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25342742.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7106054","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7106054.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}